---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-022945"
form_type: "8-K"
ticker: "SIGY"
cik: "0001642159"
company_name: "Sigyn Therapeutics, Inc."
filed_at: "2024-06-06T23:59:59+00:00"
generated_at: "2026-06-01T05:55:14.566536+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Sigyn Therapeutics reports conversion of $226,903 in debentures at $6.00 per share, issuing 37,820 shares.

## Summary
- Holders converted $226,903 of Original Issue Discount Senior Convertible Debentures at avg. exercise price of $6.00/share.
- Company issued 37,820 shares of common stock to debenture holders.
- Outstanding common shares increased from 1,225,833 to 1,263,653 as a result.
- Conversions occurred from May 30 to June 6, 2024.

## SEC filing metadata
- accession: 0001493152-24-022945
- form_type: 8-K
- ticker: SIGY
- cik: 0001642159
- company_name: Sigyn Therapeutics, Inc.
- filed_at: 2024-06-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1642159/000149315224022945/0001493152-24-022945-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1642159/000149315224022945/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-022945
- JSON: https://secwatch.observer/filing/0001493152-24-022945.json
- Plain text: https://secwatch.observer/filing/0001493152-24-022945.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.